Evidence map›Paper›PMID 41891964›Full record

ReviewMolecular medicine reports2026

Photodynamic therapy: A paradigm shift in overcoming drug‑resistant tuberculosis (Review).

Shuhao Cheng, Yuqing Wang, Jie Yao, Guodong Cheng, Gengzhi Ye, Fapeng Shi, Xiaolei Ma

Abstract readReview
In one paragraph

Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuhao ChengClinical Medical College, Qinghai University, Xining, Qinghai 810016, P.R. China.
Yuqing WangDepartment of Respiratory Medicine I, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai 810000, P.R. China.
Jie YaoDepartment of Respiratory Medicine I, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai 810000, P.R. China.
Guodong ChengDepartment of Respiratory Medicine I, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai 810000, P.R. China.
Gengzhi YeDepartment of Respiratory Medicine I, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai 810000, P.R. China.
Fapeng ShiDepartment of Respiratory Medicine I, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai 810000, P.R. China.
Xiaolei MaDepartment of Respiratory Medicine I, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai 810000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) poses a notable threat to global public health. Conventional antibiotic treatments are hampered by long treatment courses, notable toxicity and rising levels of drug resistance. By contrast, photodynamic therapy (PDT) offers a promising alternative to antibiotics. This approach employs photosensitizers (PSs), light and oxygen to generate reactive oxygen species, which induce oxidative stress to eliminate

Indexed as

Mycobacterium tuberculosisPhotochemotherapyPhotosensitizing AgentsTuberculosis, Multidrug-ResistantAnimalsAntitubercular AgentsBiofilmsHumansReactive Oxygen SpeciesAntitubercular AgentsPhotosensitizing AgentsReactive Oxygen Speciesbiofilmdrug resistanceMTBnanomedicinePDTtargeted deliveryTB

Identifiers

PMID41891964
PMCPMC13051530

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.